These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7600 related articles for article (PubMed ID: 1917133)
1. Effects of HC antibody in autologous tumor-specific cytotoxicity by human melanoma tumor-infiltrating lymphocytes. Mansfield PF; Salmeron MA; Rosenblum MG; Itoh K Int J Cancer; 1991 Sep; 49(3):356-61. PubMed ID: 1917133 [TBL] [Abstract][Full Text] [Related]
2. Augmentation of interleukin-2-induced activation of human melanoma tumor-infiltrating lymphocytes by heteroconjugate antibody. Mansfield PF; Rosenblum MG; Murray JL; Itoh K Cancer Immunol Immunother; 1991; 33(4):247-54. PubMed ID: 1829394 [TBL] [Abstract][Full Text] [Related]
3. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor. Itoh K; Platsoucas CD; Balch CM J Exp Med; 1988 Oct; 168(4):1419-41. PubMed ID: 3262710 [TBL] [Abstract][Full Text] [Related]
4. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma. Mukherji B; Guha A; Chakraborty NG; Sivanandham M; Nashed AL; Sporn JR; Ergin MT J Exp Med; 1989 Jun; 169(6):1961-76. PubMed ID: 2471770 [TBL] [Abstract][Full Text] [Related]
5. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer. Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469 [TBL] [Abstract][Full Text] [Related]
6. Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction. Hom SS; Topalian SL; Simonis T; Mancini M; Rosenberg SA J Immunother (1991); 1991 Jun; 10(3):153-64. PubMed ID: 1868040 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of in vitro tumor-infiltrating lymphocyte cytotoxicity by heteroconjugated antibodies. Reid I; Lundy J; Donohue JH J Immunol; 1992 Apr; 148(8):2630-5. PubMed ID: 1532818 [TBL] [Abstract][Full Text] [Related]
8. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone. Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931 [TBL] [Abstract][Full Text] [Related]
9. Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide. Salgaller ML; Weber JS; Koenig S; Yannelli JR; Rosenberg SA Cancer Immunol Immunother; 1994 Aug; 39(2):105-16. PubMed ID: 7519125 [TBL] [Abstract][Full Text] [Related]
10. Role of uncultured human melanoma cells in the proliferation of autologous tumor-specific cytotoxic T lymphocytes. Salmeron MA; Balch CM; Ross MI; Itoh K Cell Immunol; 1992 Aug; 143(1):228-37. PubMed ID: 1623565 [TBL] [Abstract][Full Text] [Related]
11. Heteroconjugate antibody-directed killing of autologous human renal carcinoma cells by in vitro-activated lymphocytes. Kerr L; Huntoon C; Donohue J; Leibson PJ; Bander NH; Ghose T; Luner SJ; Vessella R; McKean DJ J Immunol; 1990 May; 144(10):4060-7. PubMed ID: 2139677 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies. Wong JT; Pinto CE; Gifford JD; Kurnick JT; Kradin RL J Immunol; 1989 Nov; 143(10):3404-11. PubMed ID: 2509557 [TBL] [Abstract][Full Text] [Related]
13. Growth and autologous tumor lysis by tumor-infiltrating lymphocytes from metastatic melanoma expanded in interleukin-2 or interleukin-2 plus interleukin-4. Lindgren CG; Thompson JA; Higuchi CM; Fefer A J Immunother Emphasis Tumor Immunol; 1993 Nov; 14(4):322-8. PubMed ID: 8280715 [TBL] [Abstract][Full Text] [Related]
14. Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas. Kawakami Y; Zakut R; Topalian SL; Stötter H; Rosenberg SA J Immunol; 1992 Jan; 148(2):638-43. PubMed ID: 1729379 [TBL] [Abstract][Full Text] [Related]
15. Lymphokine production by human melanoma tumor-infiltrating lymphocytes. Salmeron MA; Morita T; Seki H; Platsoucas CD; Itoh K Cancer Immunol Immunother; 1992; 35(3):211-7. PubMed ID: 1386286 [TBL] [Abstract][Full Text] [Related]
16. Characterization of autologous tumor-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma. Kharkevitch DD; Seito D; Balch GC; Maeda T; Balch CM; Itoh K Int J Cancer; 1994 Aug; 58(3):317-23. PubMed ID: 7914181 [TBL] [Abstract][Full Text] [Related]
17. Differential regulation by interleukin-4 and interferon-gamma of an autologous melanoma-specific cytotoxic T-cell clone and the tumor-infiltrating lymphocytes from which it was established. Yamada T; Holmes EC; Golub SH Cancer Commun; 1990; 2(3):113-21. PubMed ID: 2114166 [TBL] [Abstract][Full Text] [Related]
18. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma. Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875 [TBL] [Abstract][Full Text] [Related]
19. Lymphocytes infiltrating human ovarian tumors. I. Role of Leu-19 (NKH1)-positive recombinant IL-2-activated cultures of lymphocytes infiltrating human ovarian tumors. Heo DS; Whiteside TL; Kanbour A; Herberman RB J Immunol; 1988 Jun; 140(11):4042-9. PubMed ID: 3286766 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interaction. Anichini A; Mazzocchi A; Fossati G; Parmiani G J Immunol; 1989 May; 142(10):3692-701. PubMed ID: 2469723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]